Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
39.33
0.00 (0.00%)
At close: May 6, 2026

SHE:301281 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
363.6359.08178.13325.22148.9766.01
Short-Term Investments
---210.26--
Trading Asset Securities
--254.43150.54--
Cash & Short-Term Investments
363.6359.08432.56686.02148.9766.01
Cash Growth
-8.56%-16.99%-36.95%360.50%125.69%76.29%
Accounts Receivable
198.13117.9795.8575.8556.8743.71
Other Receivables
13.3512.3227.110.650.310.69
Receivables
211.48130.29122.9676.557.1844.4
Inventory
141.48147.45128.94108.0567.9286.44
Other Current Assets
15.0115.576.268.228.26.53
Total Current Assets
731.57652.39690.73878.79282.27203.38
Property, Plant & Equipment
683.33679.36477314.2308.83290.27
Long-Term Investments
190.92191.52190.31184.08--
Goodwill
1.031.031.82---
Other Intangible Assets
112.94112.74107.1746.0249.0851.76
Long-Term Deferred Tax Assets
4.344.263.062.922.091.62
Long-Term Deferred Charges
2.613.592.390.731.733.15
Other Long-Term Assets
64.0642.7879.9843.227.799.34
Total Assets
1,7911,6881,5521,470651.79559.51
Accounts Payable
102.94105.6542.2550.1854.9860.58
Accrued Expenses
12.9149.644.5939.7129.2323.65
Short-Term Debt
39.44-----
Current Income Taxes Payable
9.3501.080-4.59
Current Unearned Revenue
6.416.7720.243.53.023.09
Other Current Liabilities
68.6313.9611.6317.7520.6418.83
Total Current Liabilities
239.67175.99119.78111.14107.86110.75
Long-Term Debt
117.15112.3445.66---
Long-Term Unearned Revenue
7.868.419.2710.539.0410.11
Long-Term Deferred Tax Liabilities
16.2718.2917.7817.2515.167.66
Other Long-Term Liabilities
16.4516.450.38---
Total Liabilities
397.4331.48192.87138.93132.06128.52
Common Stock
108.29108.29108.29108.295858
Additional Paid-In Capital
912.8907.68907.67909.97195.34195.34
Retained Earnings
365.23335.16340.26312.3266.2174.93
Comprehensive Income & Other
5.984.422.570.480.192.72
Total Common Equity
1,3921,3561,3591,331519.73430.98
Minority Interest
1.090.630.81---
Shareholders' Equity
1,3931,3561,3601,331519.73430.98
Total Liabilities & Equity
1,7911,6881,5521,470651.79559.51
Total Debt
156.58112.3445.66---
Net Cash (Debt)
207.02246.73386.9686.02148.9766.01
Net Cash Growth
-37.45%-36.23%-43.60%360.50%125.69%76.29%
Net Cash Per Share
1.882.243.586.771.830.81
Filing Date Shares Outstanding
108.29108.29108.29108.2981.281.2
Total Common Shares Outstanding
108.29108.29108.29108.2981.281.2
Working Capital
491.9476.4570.95767.65174.492.64
Book Value Per Share
12.8612.5212.5512.296.405.31
Tangible Book Value
1,2781,2421,2501,285470.65379.23
Tangible Book Value Per Share
11.8011.4711.5411.875.804.67
Buildings
-220.06216.15213.26208.05186.34
Machinery
-373.66342.54316.21275.82210.37
Construction In Progress
-390.16183.1512.1519.9966.23
Source: S&P Global Market Intelligence. Standard template. Financial Sources.